This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Albig, A. R. Articles by Schiemann, W. P. Search for Related Content PubMed PubMed Citation Articles by Albig, A. R. Articles by Schiemann, W. P.

Fibulins 3 and 5 Antagonize Tumor Angiogenesis In vivo

Program in Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado

Requests for reprints: William P. Schiemann, Program in Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Goodman Building K1003B, 1400 Jackson Street, Denver, CO 80206. Phone: 303-398-1551; Fax: 303-398-1225; E-mail: schiemannwp{at}njc.org.

Lethal tumor growth and progression cannot occur without angiogenesis, which facilitates cancer cell proliferation, survival, and dissemination. Fibulins (FBLN) 5 and 3 are widely expressed extracellular matrix proteins that regulate cell proliferation in a context-specific manner. Reduced FBLN-5 expression has been associated with cancer formation and progression in humans, whereas its constitutive expression antagonizes endothelial cell angiogenic sprouting in vitro. Thus, FBLN-5 may suppress tumorigenesis by preventing tumor angiogenesis. FBLN-3 is homologous to FBLN-5 and expressed in endothelial cells, yet its role in tumorigenesis and angiogenesis is unknown. We find FBLN-3 expression to be altered in some human tumors and that its constitutive expression in endothelial cells inhibited their proliferation, invasion, and angiogenic sprouting, as well as their response to vascular endothelial growth factor as measured by p38 mitogen-activated protein kinase activation. In endothelial cells, both FBLNs (a) reduced angiogenic sprouting stimulated by basic fibroblast growth factor (bFGF); (b) inhibited matrix metalloproteinase expression and activity; and (c) stimulated tissue inhibitor of metalloproteinase expression. More importantly, both FBLNs prevented angiogenesis and vessel infiltration into bFGF-supplemented Matrigel plugs implanted in genetically normal mice, as well as decreased the growth and blood vessel density in tumors produced by MCA102 fibrosarcoma cells implanted s.c. into syngeneic mice. Our findings establish FBLN-3 and FBLN-5 as novel angiostatic agents capable of reducing tumor angiogenesis and, consequently, tumor growth in vivo and suggest that these angiostatic activities may one day be exploited to combat tumor angiogenesis and metastasis in cancer patients. (Cancer Res 2006; 66(5): 2621-9)

This article has been cited by other articles:

				B. Ulmasov, J. Bruno, N. Gordon, M. E. Hartnett, and J. C. Edwards Chloride Intracellular Channel Protein-4 Functions in Angiogenesis by Supporting Acidification of Vacuoles Along the Intracellular Tubulogenic Pathway Am. J. Pathol., March 1, 2009; 174(3): 1084 - 1096. [Abstract] [Full Text] [PDF]

				H. Seeliger, P. Camaj, I. Ischenko, A. Kleespies, E. N. De Toni, S. E. Thieme, H. Blum, G. Assmann, K.-W. Jauch, and C. J. Bruns EFEMP1 Expression Promotes In vivo Tumor Growth in Human Pancreatic Adenocarcinoma Mol. Cancer Res., February 1, 2009; 7(2): 189 - 198. [Abstract] [Full Text] [PDF]

				Y.-H. Lee, A. R. Albig, M. Regner, B. J. Schiemann, and W. P. Schiemann Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-{beta} in mammary epithelial cells via a MMP-dependent mechanism Carcinogenesis, December 1, 2008; 29(12): 2243 - 2251. [Abstract] [Full Text] [PDF]

				L. Xie, K. Palmsten, B. MacDonald, M. W. Kieran, S. Potenta, S. Vong, and R. Kalluri Basement Membrane Derived Fibulin-1 and Fibulin-5 Function as Angiogenesis Inhibitors and Suppress Tumor Growth Experimental Biology and Medicine, February 1, 2008; 233(2): 155 - 162. [Abstract] [Full Text] [PDF]

				P. J. McLaughlin, B. Bakall, J. Choi, Z. Liu, T. Sasaki, E. C. Davis, A. D. Marmorstein, and L. Y. Marmorstein Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice Hum. Mol. Genet., December 15, 2007; 16(24): 3059 - 3070. [Abstract] [Full Text] [PDF]

				L. Y. Marmorstein, P. J. McLaughlin, N. S. Peachey, T. Sasaki, and A. D. Marmorstein Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration Hum. Mol. Genet., October 15, 2007; 16(20): 2423 - 2432. [Abstract] [Full Text] [PDF]

				W. Yue, S. Dacic, Q. Sun, R. Landreneau, M. Guo, W. Zhou, J. M. Siegfried, J. Yu, and L. Zhang Frequent Inactivation of RAMP2, EFEMP1 and Dutt1 in Lung Cancer by Promoter Hypermethylation Clin. Cancer Res., August 1, 2007; 13(15): 4336 - 4344. [Abstract] [Full Text] [PDF]

				N. Kobayashi, G. Kostka, J. H. O. Garbe, D. R. Keene, H. P. Bachinger, F.-G. Hanisch, D. Markova, T. Tsuda, R. Timpl, M.-L. Chu, et al. A Comparative Analysis of the Fibulin Protein Family: BIOCHEMICAL CHARACTERIZATION, BINDING INTERACTIONS, AND TISSUE LOCALIZATION J. Biol. Chem., April 20, 2007; 282(16): 11805 - 11816. [Abstract] [Full Text] [PDF]

				B. Davidson, Z. Zhang, L. Kleinberg, M. Li, V. A. Florenes, T.-L. Wang, and I.-M. Shih Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma. Clin. Cancer Res., October 15, 2006; 12(20): 5944 - 5950. [Abstract] [Full Text] [PDF]